Tomocube, Inc. (KOSDAQ:475960)

Market Cap	601.58B +152.1%
Revenue (ttm)	11.31B +90.4%
Net Income	-4.81B
EPS	-365.00
Shares Out	13.38M
PE Ratio	n/a
Forward PE	165.87
Dividend	n/a
Ex-Dividend Date	n/a

Volume	74,145
Average Volume	124,974
Open	44,950
Previous Close	44,950
Day's Range	42,500 - 45,000
52-Week Range	22,500 - 67,800
Beta	n/a
RSI	31.51
Earnings Date	Apr 3, 2026

About Tomocube

Tomocube, Inc. engages in the manufacture and sale of optical devices and medical equipment. Its holotomography (HT) products include HT-X1 for live-cell imaging and analysis; and HT-2H for 3D live cell imaging. The company also offers TomoAnalysis, a 3D image visualization and analysis software. In addition, it provides accessories, such as HT-ready 96 well plates; TomoDish that is designed to accommodate both adherent and suspension cells; TomoChamber, a stage-top incubator designed for long-term live cell imaging; TomoPlate, an active vibrat...

• Founded: 2015
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 475960

Financial Performance

In 2025, Tomocube's revenue was 11.31 billion, an increase of 90.39% compared to the previous year's 5.94 billion. Losses were -4.81 billion, -42.06% less than in 2024.